Identification of a ferroptosis-related gene signature for predicting the prognosis of cholangiocarcinoma

被引:7
作者
Wang, Ziyi [1 ]
Zhang, Yaodong [1 ]
Chen, Yananlan [1 ]
Liu, Shuochen [1 ]
Li, Changxian [1 ]
Li, Xiangcheng [1 ]
机构
[1] Nanjing Med Univ, Dept Liver Surg, Key Lab Living Donor Liver Transplantat, Minist Hlth,Affiliated Hosp 1, Nanjing, Peoples R China
基金
美国国家科学基金会;
关键词
Cholangiocarcinoma; ferroptosis; risk signature; immune cell infiltration; CELL-DEATH; HEPATOCELLULAR-CARCINOMA; METABOLISM; THERAPY;
D O I
10.1080/17474124.2022.2029700
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background Cholangiocarcinoma (CCA) is a highly intractable malignancy with poor prognosis. Ferroptosis, a newly explored type of programmed cell death, plays a critical role in the initiation and progression of a tumor. Herein, we aimed to identify a ferroptosis-related risk model to evaluate the prognosis of CCA. Methods Differentially expressed genes (DEGs) were retrieved from three GEO cohorts. Univariate and LASSO analysis were employed to build a ferroptosis-related gene signature. Next, the predictive value was assessed in a training and a validation cohort. Metascape Online analysis, ESTIMATE and CIBERSORT algorithms, and ssGSEA were employed to perform the functional analysis between different risk groups. Finally, the expression of prognostic genes was validated with RT-qPCR. Results We identified 51 differentially expressed ferroptosis genes and established the prognostic signature containing five ferroptosis-related genes. The K-M curves and the ROC curves revealed a favorable predictive efficacy of the prognostic signature. Functional enrichment analysis indicated that immune-related responses were greatly enriched between different risk groups. Five prognostic genes were also differentially expressed in CCA cell lines. Conclusions We developed a novel ferroptosis-related gene signature for CCA with high predictive accuracy. The analysis of the immune infiltration status may provide a potential therapeutic alternative to CCA.
引用
收藏
页码:181 / 191
页数:11
相关论文
共 50 条
[1]   Prognostic subclass of intrahepatic cholangiocarcinoma by integrative molecular-clinical analysis and potential targeted approach [J].
Ahn, Keun Soo ;
O'Brien, Daniel ;
Kang, Yu Na ;
Mounajjed, Taofic ;
Kim, Yong Hoon ;
Kim, Tae-Seok ;
Kocher, Jean-Pierre A. ;
Allotey, Loretta K. ;
Borad, Mitesh J. ;
Roberts, Lewis R. ;
Kang, Koo Jeong .
HEPATOLOGY INTERNATIONAL, 2019, 13 (04) :490-500
[2]   Genomic and Genetic Characterization of Cholangiocarcinoma Identifies Therapeutic Targets for Tyrosine Kinase Inhibitors [J].
Andersen, Jesper B. ;
Spee, Bart ;
Blechacz, Boris R. ;
Avital, Itzhak ;
Komuta, Mina ;
Barbour, Andrew ;
Conner, Elizabeth A. ;
Gillen, Matthew C. ;
Roskams, Tania ;
Roberts, Lewis R. ;
Factor, Valentina M. ;
Thorgeirsson, Snorri S. .
GASTROENTEROLOGY, 2012, 142 (04) :1021-U552
[3]   Common Molecular Subtypes Among Asian Hepatocellular Carcinoma and Cholangiocarcinoma [J].
Chaisaingmongkol, Jittiporn ;
Budhu, Anuradha ;
Dang, Hien ;
Rabibhadana, Siritida ;
Pupacdi, Benjarath ;
Kwon, So Mee ;
Forgues, Marshonna ;
Pomyen, Yotsawat ;
Bhudhisawasdi, Vajarabhongsa ;
Lertprasertsuke, Nirush ;
Chotirosniramit, Anon ;
Pairojkul, Chawalit ;
Auewarakul, Chirayu U. ;
Sricharunrat, Thaniya ;
Phornphutkul, Kannika ;
Sangrajrang, Suleeporn ;
Cam, Maggie ;
He, Ping ;
Hewitt, Stephen M. ;
Ylaya, Kris ;
Wu, Xiaolin ;
Andersen, Jesper B. ;
Thorgeirsson, Snorri S. ;
Waterfall, Joshua J. ;
Zhu, Yuelin J. ;
Walling, Jennifer ;
Stevenson, Holly S. ;
Edelman, Daniel ;
Meltzer, Paul S. ;
Loffredo, Christopher A. ;
Hama, Natsuko ;
Shibata, Tatsuhiro ;
Wiltrout, Robert H. ;
Harris, Curtis C. ;
Mahidol, Chulabhorn ;
Ruchirawat, Mathuros ;
Wang, Xin W. .
CANCER CELL, 2017, 32 (01) :57-+
[4]   Five Hub Genes Can Be The Potential DNA Methylation Biomarkers For Cholangiocarcinoma Using Bioinformatics Analysis [J].
Chen, Diyu ;
Wu, Hao ;
He, Bin ;
Lu, Yuejie ;
Wu, Wenxuan ;
Liu, Hua ;
Feng, Xiaode ;
Chen, Jianzhong ;
Wu, Jian .
ONCOTARGETS AND THERAPY, 2019, 12 :8355-8365
[5]   ACSL4 reprograms fatty acid metabolism in hepatocellular carcinoma via c-Myc/SREBP1 pathway [J].
Chen, Junru ;
Ding, Chaofeng ;
Chen, Yunhao ;
Hu, Wendi ;
Yu, Chengkuan ;
Peng, Chuanhui ;
Feng, Xiaode ;
Cheng, Qiyang ;
Wu, Wenxuan ;
Lu, Yuejie ;
Xie, Haiyang ;
Zhou, Lin ;
Wu, Jian ;
Zheng, Shusen .
CANCER LETTERS, 2021, 502 :154-165
[6]   The role of tumour microenvironment: a new vision for cholangiocarcinoma [J].
Chen, Ziyan ;
Guo, Pengyi ;
Xie, Xiaozai ;
Yu, Haitao ;
Wang, Yi ;
Chen, Gang .
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2019, 23 (01) :59-69
[7]   Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death [J].
Dixon, Scott J. ;
Lemberg, Kathryn M. ;
Lamprecht, Michael R. ;
Skouta, Rachid ;
Zaitsev, Eleina M. ;
Gleason, Caroline E. ;
Patel, Darpan N. ;
Bauer, Andras J. ;
Cantley, Alexandra M. ;
Yang, Wan Seok ;
Morrison, Barclay, III ;
Stockwell, Brent R. .
CELL, 2012, 149 (05) :1060-1072
[8]  
Doll S, 2017, NAT CHEM BIOL, V13, P91, DOI [10.1038/NCHEMBIO.2239, 10.1038/nchembio.2239]
[9]   The tumour microenvironment and immune milieu of cholangiocarcinoma [J].
Fabris, Luca ;
Perugorria, Maria J. ;
Mertens, Joachim ;
Bjorkstrom, Niklas K. ;
Cramer, Thorsten ;
Lleo, Ana ;
Solinas, Antonio ;
Saenger, Hanna ;
Lukacs-Kornek, Veronika ;
Moncsek, Anja ;
Siebenhuner, Alexander ;
Strazzabosco, Mario .
LIVER INTERNATIONAL, 2019, 39 :63-78
[10]   Prolonged Response to Anti-PD-1 Antibody Therapy in Chemotherapy-Refractory Cholangiocarcinoma With High Tumor Mutational Burden [J].
Gbolahan, Olumide ;
Hashemi-Sadraei, Neda ;
O'Neil, Bert .
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2019, 17 (06) :644-648